| Literature DB >> 32140149 |
France Anne Dias Ruas1, Renata Guerra-Sá1.
Abstract
Recently, there has been an increasing interest in the use of yeast to produce biosorbent materials, because yeast is economical to use, adaptable to a variety of conditions, and amenable to morphological manipulations to yield better raw biomaterials. Previous studies from our laboratory have shown that Meyerozyma guilliermondii, a non-pathogenic haploid yeast (ascomycete), exhibits excellent biosorption capacity for Mn2+, as demonstrated by kinetic analyses. Shotgun/bottom-up analyses of soluble fractions revealed a total of 1257 identified molecules, with 117 proteins expressed in the absence of Mn2+ and 69 expressed only in the presence of Mn2+. In this article, we describe the first in silico prediction and screening of protein-protein interactions (PPIs) in M. guilliermondii using experimental data from shotgun/bottom-up analyses. We also present the categorization of biological processes (BPs), molecular functions (MFs), and metabolic pathways of 71 proteins upregulated in the M. guilliermondii proteome in response to stress caused by an excess of Mn2+ ions. Most of the annotated proteins were related to oxidation-reduction processes, metabolism, and response to oxidative stress. We identified seven functional enrichments and 42 metabolic pathways; most proteins belonged to pathways related to metabolic pathways (19 proteins) followed by the biosynthesis of secondary metabolites (10 proteins) in the presence of Mn2+. Using our data, it is possible to infer that defense mechanisms minimize the impact of Mn2+ via the expression of antioxidant proteins, thus allowing adjustment during the defense response. Previous studies have not considered protein interactions in this genus in a manner that permits comparisons. Consequently, the findings of the current study are innovative, highly relevant, and provide a description of interactive complexes and networks that yield insight into the cellular processes of M. guilliermondii. Collectively, our data will allow researchers to explore the biotechnological potential of M. guilliermondii in future bioremediation processes.Entities:
Keywords: Meyerozyma guilliermondii; bioremediation; manganese; metabolic pathways; protein–protein interactions; proteome
Year: 2020 PMID: 32140149 PMCID: PMC7042463 DOI: 10.3389/fmicb.2020.00236
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Heatmap representation of peptide quantification for the total proteome of M. guilliermondii based on the peak intensity of identified peptides from bottom-up proteomic data in the absence and presence of Mn2+.
FIGURE 2Network interactions of the 1257 proteins identified in the total soluble proteome of Meyerozyma guilliermondii. The most representative metabolic pathways were as follows: metabolic pathways (red), biosynthesis of secondary metabolites (blue), biosynthesis of antibiotics (green), biosynthesis of amino acids (yellow), carbon metabolism (lilac), glycolysis/gluconeogenesis cysteine and methionine metabolism (light blue), pyruvate metabolism (beige), methane metabolism (purple), and ribosome (brown) (PPI enrichment p-value: < 1.0 × 10–16).
FIGURE 3Description of the biological processes associated with upregulated proteins in the presence of Mn2+. Sequences were analyzed by Blast2GO and Gene Ontology (GO).
FIGURE 4Categorization of the molecular functions of 71 upregulated proteins in the presence of excess Mn, as determined by the bioinformatic platforms Blast2GO and Gene Ontology (GO).
FIGURE 5Network interactions of upregulated proteins in M. guilliermondii under excess Mn2+ stress, using tools and databases that can predict STRING protein function (PPI enrichment p-value: 5.29 × 10–6).
Metabolic pathways of proteins related to manganese tolerance in differential proteomes.
| Metabolic pathways | A5DFK1 A5DDM8 A5DBX1 A5DCX8 A5DQK7 | A5DQS7 A5DEL5 A5DQK9 A5DDN3 A5DQ12 | A5DHQ4 A5DRG2 A5DHJ1 A5DMR7 A5DH72 | A5D9X5 A5DL50 A5DQS2 A5DNZ9 |
| Biosynthesis of secondary metabolites | A5DFK1 A5DDM8 A5DQK9 | A5DQS7 A5DRG2 A5DHJ1 | A5DHQ4 A5DL50 | A5D9X5 A5DBX1 |
| Biosynthesis of antibiotics | A5DFK1 A5DDM8 A5DNZ9 | A5DQS7 A5DEL5 | A5DHQ4 A5DRG2 | A5D9X5 A5DBX1 |
| Biosynthesis of amino acids | A5DFK1 A5DDM8 | A5DQS7 A5DEL5 | A5DHQ4 | A5D9X5 |
| Glutathione metabolism | A5DHQ4 | A5DE26 | A5DJ25 | A5DBE9 |
| Carbon metabolism | A5DHQ4 | A5DDM8 | A5DEL5 | A5DBX1 |
| Propanoate metabolism | A5DBX1 | A5DFK3 | A5DR13 | |
| Ribosome | A5DFA0 | A5DAS9 | A5DHA7 | |
| RNA transport | A5DQ59 | A5DB30 | A5DDQ0 | |
| Longevity regulating pathway | A5DQS2 | A5DJL9 | A5DA67 | |
| Oxidative phosphorylation | A5DCX8 | A5DDN3 | ||
| Arginine biosynthesis | A5DFK1 | A5DQS7 | ||
| Purine metabolism | A5DL50 | A5DHN1 | ||
| Glycine, serine, and threonine metabolism | A5D9X5 | A5DEL5 | ||
| Amino sugar and nucleotide sugar metabolism | A5DRG2 | A5DNZ9 | ||
| Pyruvate metabolism | A5DFK3 | A5DR13 | ||
| MAPK signaling pathway | A5DFK3 | A5DR13 | ||
| Protein processing in endoplasmic reticulum | A5DNC3 | A5DB30 | ||
| Peroxisome | A5DHQ4 | A5DA67 | ||
| Glycolysis/gluconeogenesis | A5DRG2 | |||
| Citrate cycle (TCA cycle) | A5DHQ4 | |||
| Pentose and glucuronate interconversions | A5DQ12 | |||
| Galactose metabolism | A5DRG2 | |||
| Fatty acid degradation | A5DBX1 | |||
| Alanine, aspartate, and glutamate metabolism | A5DQS7 | |||
| Cysteine and methionine metabolism | A5DDM8 | |||
| Valine, leucine, and isoleucine degradation | A5DBX1 | |||
| Beta-alanine metabolism | A5DBX1 | |||
| Glycerolipid metabolism | A5DH72 | |||
| Inositol phosphate metabolism | A5DMR7 | |||
| Arachidonic acid metabolism | A5DE26 | |||
| Methane metabolism | A5DEL5 | |||
| Riboflavin metabolism | A5DHJ1 | |||
| Vitamin B6 metabolism | A5DQK7 | |||
| Nicotinate and nicotinamide metabolism | A5DQS2 | |||
| Porphyrin and chlorophyll metabolism | A5DQK9 | |||
| Sulfur metabolism | A5DDM8 | |||
| 2-Oxocarboxylic acid metabolism | A5DHQ4 | |||
| Fatty acid metabolism | A5DBX1 | |||
| mRNA surveillance pathway | A5DPP9 | |||
| Phosphatidylinositol signaling system | A5DMR7 | |||
| Endocytosis | A5DCD1 |
Differentially expressed proteins in the presence of Mn2+ ions.
| A5DBF8 | PGUG_00613 | Voltage-dependent anion channel protein 2 | 0.0 | 92.15 |
| A5DFA0 | PGUG_01951 | 40S ribosomal protein S20 | 6,51E-73 | 94.34 |
| A5DQK9 | PGUG_05560 | Uroporphyrinogen-III synthase | 0.0 | 71.25 |
| A5DCX8 | PGUG_01133 | ATP synthase subunit alpha, mitochondrial | 0.0 | 96.25 |
| A5DHA7 | PGUG_02658 | 60S ribosomal protein L9-B | 3,89E-130 | 94.64 |
| A5DDN3 | PGUG_01384 | ATP synthase subunit beta, mitochondrial | 0.0 | 97.92 |
| A5DCD1 | PGUG_00636 | Actin-related protein 2/3 complex subunit 1 | 0.0 | 84.71 |
| A5DGC8 | PGUG_02329 | Golgi vesicle protein | 0.0 | 81.12 |
| A5DFK1 | PGUG_02052 | Ornithine carbamoyltransferase | 0.0 | 85.34 |
| A5DQ59 | PGUG_05410 | Eukaryotic translation initiation factor 2 subunit gamma | 0.0 | 94.51 |
| A5DRI3 | PGUG_05884 | Karyopherin functions in nuclear transport of protein | 2,02E-135 | 81.69 |
| A5DDQ0 | PGUG_01401 | Eukaryotic translation initiation factor 1A | 4,88E-70 | 98.69 |
| A5DBE9 | PGUG_00604 | Glutathione S-transferase | 2,27E-167 | 77.01 |
| A5DBX1 | PGUG_00776 | Acyl-CoA dehydrogenase | 0.0 | 87.75 |
| A5DHQ4 | PGUG_02805 | Isocitrate dehydrogenase [NADP] peroxisomal | 0.0 | 94.86 |
| A5DQB3 | PGUG_05464 | NAD(P)-binding protein | 0.0 | 77.64 |
| A5DL50 | PGUG_04001 | Inosine-5’-monophosphate dehydrogenase | 0.0 | 94.52 |
| A5DAS9 | PGUG_00384 | Ribosomal protein L4 | 1,18E-169 | 78.33 |
| A5DQS7 | PGUG_05628 | Argininosuccinate lyase | 0.0 | 91.57 |
| A5DAY0 | PGUG_00435 | Actin/actin-like protein | 0.0 | 94.62 |
| A5DGX8 | PGUG_02529 | Predicted protein | 0.0 | 66.99 |
| A5DK41 | PGUG_03642 | Opaque-phase-specific protein OP4 | 2,64E-156 | 72.65 |
| A5DQU8 | PGUG_05649 | Putative vacuolar sorting protein | 4,53E-160 | 77.31 |
| A5DB30 | PGUG_00485 | Eukaryotic translation initiation factor 2 subunit alpha | 0.0 | 93.07 |
| A5DFH3 | PGUG_02024 | aarF domain-containing kinase | 0.0 | 83.19 |
| A5DBW2 | PGUG_00767 | Glycoside hydrolase family 81 protein | 0.0 | 82.84 |
| A5DJL9 | PGUG_03470 | P-loop containing nucleoside triphosphate hydrolase protein | 0.0 | 92.9 |
| A5DEW2 | PGUG_01813 | U1 small nuclear ribonucleoprotein | 6,07E-129 | 67.83 |
| A5DRG2 | PGUG_056863 | UDP-glucose 4-epimerase | 0.0 | 81.85 |
| A5DQ88 | PGUG_05439 | Fe-S cluster assembly protein DRE2 | 0.0 | 73.44 |
| A5DEL5 | PGUG_01716 | D-3-phosphoglycerate dehydrogenase 1 | 0.0 | 94.77 |
| A5DQ39 | PGUG_05390 | Secreted protein | 0.0 | 68.28 |
| A5DQK7 | PGUG_05558 | Pyridoxal kinase | 0.0 | 73.51 |
| A5DNY7 | PGUG_04988 | Regulation of G-protein function | 0.0 | 73.48 |
| A5DBX4 | PGUG_00779 | Actin/actin-like protein | 0.0 | 97.87 |
| A5DEQ2 | PGUG_01753 | Predicted protein | 0.0 | 69.69 |
| A5DB15 | PGUG_00470 | Elongation factor 3 | 0.0 | 95.71 |
| A5DDM8 | PGUG_01379 | Protein MET17 | 0.0 | 91.27 |
| A5DHJ1 | PGUG_02742 | 3,4-Dihydroxy-2-butanone 4-phosphate synthase | 4,37E-143 | 90.82 |
| A5DKT0 | PGUG_03881 | WD40 repeat-like protein | 8,77E-128 | 79.25 |
| A5DFT8 | PGUG_02139 | Predicted protein | 2,92E-112 | 80.51 |
| A5DKE0 | PGUG_03741 | Glyoxylate reductase 1 | 0.0 | 83.28 |
| A5DE26 | PGUG_01527 | Peroxiredoxin HYR1 | 1,91E-122 | 88.86 |
| A5DE13 | PGUG_01514 | CIP1 protein | 0.0 | 70.44 |
| A5DNZ9 | PGUG_05000 | Phosphoacetylglucosamine mutase | 0.0 | 81.25 |
| A5DRJ5 | PGUG_05896 | Protein MNN4 | 0.0 | 74.75 |
| A5DQS2 | PGUG_05623 | Nicotinamidase | 3,75E-160 | 74.04 |
| A5DRJ7 | PGUG_05898 | Probable xylose and arabinose reductase | 0.0 | 78.81 |
| A5DHN1 | PGUG_02782 | HIT-like protein | 3,69E-125 | 80.15 |
| A5DKV4 | PGUG_03905 | Cysteine hydrolase | 1,02E-130 | 73.44 |
| A5DE42 | PGUG_01543 | Lysine acetyltransferase (lysine N(6)-acetyltransferase) (LAT) | 0.0 | 67.62 |
| A5DGU4 | PGUG_02495 | FAD/NAD(P)-binding domain-containing protein | 0.0 | 73.63 |
| A5DMR7 | PGUG_04568 | Inositol-pentakisphosphate 2-kinase | 0.0 | 78.13 |
| A5D9X5 | PGUG_00080 | Threonine aldolase | 0.0 | 86.86 |
| A5DFK3 | PGUG_02054 | NADPH-dependent methylglyoxal reductase GRE2 | 1,76E-123 | 80.74 |
| A5DR09 | PGUG_05710 | SEC14 cytosolic factor | 0.0 | 89.81 |
| A5DKQ8 | PGUG_03859 | Predicted protein | 0.0 | 67.2 |
| A5DR13 | PGUG_05714 | Putative NADPH-dependent methylglyoxal reductase GRP2 | 0.0 | 72.77 |
| A5DQ12 | PGUG_05363 | Actin-like ATPase domain-containing protein | 0.0 | 82.9 |
| A5DJY5 | PGUG_03586 | Predicted protein | 2,80E-110 | 65.64 |
| A5DHM7 | PGUG_02778 | AAA-domain-containing protein | 0.0 | 82.54 |
| A5DJC5 | PGUG_03376 | JmjC domain-containing protein 4 | 0.0 | 69.22 |
| A5DNC3 | PGUG_04774 | Protein disulfide isomerase | 0.0 | 78.89 |
| A5DDJ3 | PGUG_01344 | – | ||
| A5DA67 | PGUG_00172 | Superoxide dismutase [Mn], mitochondrial | 4,53E-148 | 81.76 |
| A5DJ25 | PGUG_03276 | Glutathione S-transferase | 2,58E-170 | 76.38 |
| A5DAB9 | PGUG_00224 | Transcriptional regulator of the CTR1 copper transporter | 0.0 | 62.06 |
| A5DLT5 | PGUG_04236 | Predicted protein | 0.0 | 60.57 |
| A5DAB7 | PGUG_00222 | Molybdopterin binding protein | 0.0 | 78.3 |
| A5DH72 | PGUG_02623 | HAD hydrolase, family IA | 0.0 | 92.99 |
| A5DPP9 | PGUG_05250 | Protein MPE1 | 3,27E-159 | 80.88 |